These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4900 related items for PubMed ID: 7506580

  • 1. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ, Kirkpatrick G, Sabiston N, Peters W, Kurtzberg J.
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM, Fortuna A, Fogli M, Rosti G, Gherlinzoni F, Visani G, Catani L, Gozzetti A, Tura S.
    Acta Haematol; 1996 Dec; 95(3-4):164-70. PubMed ID: 8677737
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J.
    Blood; 1993 Apr 01; 81(7):1709-19. PubMed ID: 7681699
    [Abstract] [Full Text] [Related]

  • 5. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
    Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Gilbert CJ, Oette DH.
    N Engl J Med; 1988 Apr 07; 318(14):869-76. PubMed ID: 3281007
    [Abstract] [Full Text] [Related]

  • 6. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
    Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein A, Rubin P, Ross M, Gilbert C, Modlin C, Meisenberg B, Coniglio D, Rabinowitz J, Laughlin M, Kurtzberg J, Peters WP.
    Bone Marrow Transplant; 1997 Feb 07; 19(4):315-22. PubMed ID: 9051240
    [Abstract] [Full Text] [Related]

  • 7. Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.
    Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F.
    Blood; 1992 May 15; 79(10):2583-91. PubMed ID: 1586711
    [Abstract] [Full Text] [Related]

  • 8. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.
    Haematologica; 1999 Nov 15; 84(11):1016-23. PubMed ID: 10553163
    [Abstract] [Full Text] [Related]

  • 9. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
    Lazarus HM, Andersen J, Chen MG, Variakojis D, Mansour EG, Oette D, Arce CA, Oken MM, Gerson SL.
    Blood; 1991 Aug 01; 78(3):830-7. PubMed ID: 1859894
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar 01; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 11. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM, Nayar R, Baker MA, Sutton DM, Scott JG, Sutcliffe SB, Keating A.
    Exp Hematol; 1991 Mar 01; 19(3):191-5. PubMed ID: 1995310
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
    Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, Fleming NC, Bonnem EM, Greenberg PL.
    Ann Intern Med; 1992 Feb 01; 116(3):183-9. PubMed ID: 1345803
    [Abstract] [Full Text] [Related]

  • 13. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM, Bierman PJ, Ruby E, Reed EC, Bishop MR, Tarantolo S, Kessinger A, Armitage JO.
    Bone Marrow Transplant; 1996 Jun 01; 17(6):951-6. PubMed ID: 8807099
    [Abstract] [Full Text] [Related]

  • 14. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN, Lazarus HM, Rademaker A, Villa M, Mangan C, Tallman M, Jahnke L, Gordon L, Newman S, Byrd K, Cooper BW, Horvath N, Crum E, Stadtmauer EA, Conklin E, Bauman A, Martin J, Goolsby C, Gerson SL, Bender J, O'Gorman M.
    J Clin Oncol; 1996 Jan 01; 14(1):277-86. PubMed ID: 8558209
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
    Vose JM, Pandite AN, Beveridge RA, Geller RB, Schuster MW, Anderson JE, LeMaistre CF, Ahmed T, Granena A, Keating A, Fernandez Ranada JM, Stiff PJ, Tabbara I, Longo W, Copelan EA, Nichols C, Smith A, Topolsky DL, Bierman PJ, Lebsack ME, Lange M, Garrison L.
    J Clin Oncol; 1997 Apr 01; 15(4):1617-23. PubMed ID: 9193361
    [Abstract] [Full Text] [Related]

  • 16. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ, van Eijk L, Schipper P, Löwenberg B.
    Exp Hematol; 1989 Mar 01; 17(3):292-5. PubMed ID: 2645158
    [Abstract] [Full Text] [Related]

  • 17. Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation.
    Stewart FM, Temeles D, Lowry P, Thraves T, Grosh WW, Quesenberry PJ.
    Blood; 1993 May 01; 81(9):2283-9. PubMed ID: 8481510
    [Abstract] [Full Text] [Related]

  • 18. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.
    Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB.
    Blood; 1995 Jun 15; 85(12):3452-6. PubMed ID: 7540062
    [Abstract] [Full Text] [Related]

  • 19. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
    Janowska-Wieczorek A, Marquez LA, Nabholtz JM, Cabuhat ML, Montaño J, Chang H, Rozmus J, Russell JA, Edwards DR, Turner AR.
    Blood; 1999 May 15; 93(10):3379-90. PubMed ID: 10233890
    [Abstract] [Full Text] [Related]

  • 20. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L, Cartron G, Roingeard F, Delain M, Degenne M, Linassier C, Hérault O, Truglio D, Bout M, Petit A, Brémond JL, Desbois I, Colombat P, Binet C, Domenech J.
    Exp Hematol; 2003 Jan 15; 31(1):89-97. PubMed ID: 12543111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 245.